Titre : Flavonols

Flavonols : Questions médicales fréquentes

Termes MeSH sélectionnés :

Evidence-Based Practice
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Flavonols : Questions médicales les plus fréquentes", "headline": "Flavonols : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Flavonols : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-05-13", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Flavonols" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Flavonoïdes", "url": "https://questionsmedicales.fr/mesh/D005419", "about": { "@type": "MedicalCondition", "name": "Flavonoïdes", "code": { "@type": "MedicalCode", "code": "D005419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Kaempférols", "alternateName": "Kaempferols", "url": "https://questionsmedicales.fr/mesh/D044949", "about": { "@type": "MedicalCondition", "name": "Kaempférols", "code": { "@type": "MedicalCode", "code": "D044949", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.388" } } }, { "@type": "MedicalWebPage", "name": "Quercétine", "alternateName": "Quercetin", "url": "https://questionsmedicales.fr/mesh/D011794", "about": { "@type": "MedicalCondition", "name": "Quercétine", "code": { "@type": "MedicalCode", "code": "D011794", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.777" } } }, { "@type": "MedicalWebPage", "name": "Rutoside", "alternateName": "Rutin", "url": "https://questionsmedicales.fr/mesh/D012431", "about": { "@type": "MedicalCondition", "name": "Rutoside", "code": { "@type": "MedicalCode", "code": "D012431", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "O-(bêta-Hydroxyéthyl)rutosides", "alternateName": "Hydroxyethylrutoside", "url": "https://questionsmedicales.fr/mesh/D006896", "about": { "@type": "MedicalCondition", "name": "O-(bêta-Hydroxyéthyl)rutosides", "code": { "@type": "MedicalCode", "code": "D006896", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D03.633.100.150.266.450.284.888.500" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Flavonols", "alternateName": "Flavonols", "code": { "@type": "MedicalCode", "code": "D044948", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Changjie Xu", "url": "https://questionsmedicales.fr/author/Changjie%20Xu", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Kunsong Chen", "url": "https://questionsmedicales.fr/author/Kunsong%20Chen", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Xian Li", "url": "https://questionsmedicales.fr/author/Xian%20Li", "affiliation": { "@type": "Organization", "name": "Zhejiang Provincial Key Laboratory of Horticultural Plant Integrative Biology, Zhejiang University, Hangzhou 310058, China." } }, { "@type": "Person", "name": "Wei Xue", "url": "https://questionsmedicales.fr/author/Wei%20Xue", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals, Guizhou University, Guiyang, 550025, China. wxue@gzu.edu.cn." } }, { "@type": "Person", "name": "Nguyen Xuan Nhiem", "url": "https://questionsmedicales.fr/author/Nguyen%20Xuan%20Nhiem", "affiliation": { "@type": "Organization", "name": "Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi, Vietnam." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Instruments for assessing healthcare professionals' knowledge and skills of evidence-based practice: A scoping review.", "datePublished": "2022-10-13", "url": "https://questionsmedicales.fr/article/36229896", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jocn.16506" } }, { "@type": "ScholarlyArticle", "name": "How nursing stakeholders in the Republic of Ireland define evidence-based practice and why it matters.", "datePublished": "2022-06-16", "url": "https://questionsmedicales.fr/article/35711099", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/wvn.12593" } }, { "@type": "ScholarlyArticle", "name": "[Implementation of a checklist improves adherence to evidence-based practices in a pediatric intensive therapy unit].", "datePublished": "2022-06-06", "url": "https://questionsmedicales.fr/article/35700461", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.31053/1853.0605.v79.n2.34210" } }, { "@type": "ScholarlyArticle", "name": "Chinese guidelines for the rehabilitation treatment of knee osteoarthritis: An CSPMR evidence-based practice guideline.", "datePublished": "2023-09-24", "url": "https://questionsmedicales.fr/article/37743650", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/jebm.12555" } }, { "@type": "ScholarlyArticle", "name": "Nursing managers' perspectives on facilitators of and barriers to evidence-based practice: A cross-sectional study.", "datePublished": "2023-06-12", "url": "https://questionsmedicales.fr/article/37306392", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/nop2.1864" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés hétérocycliques", "item": "https://questionsmedicales.fr/mesh/D006571" }, { "@type": "ListItem", "position": 3, "name": "Composés hétérocycliques à cycles fusionnés", "item": "https://questionsmedicales.fr/mesh/D000072471" }, { "@type": "ListItem", "position": 4, "name": "Composés hétérobicycliques", "item": "https://questionsmedicales.fr/mesh/D006574" }, { "@type": "ListItem", "position": 5, "name": "Benzopyranes", "item": "https://questionsmedicales.fr/mesh/D001578" }, { "@type": "ListItem", "position": 6, "name": "4H-1-Benzopyran-4-ones", "item": "https://questionsmedicales.fr/mesh/D002867" }, { "@type": "ListItem", "position": 7, "name": "Flavonoïdes", "item": "https://questionsmedicales.fr/mesh/D005419" }, { "@type": "ListItem", "position": 8, "name": "Flavonols", "item": "https://questionsmedicales.fr/mesh/D044948" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Flavonols - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Flavonols", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Flavonols", "description": "Comment détecte-t-on les flavonols dans les aliments ?\nQuels tests mesurent les niveaux de flavonols dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Evidence-Based+Practice&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Flavonols", "description": "Les flavonols provoquent-ils des symptômes ?\nQuels effets des flavonols sur la santé ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Evidence-Based+Practice&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Flavonols", "description": "Comment les flavonols aident-ils à prévenir les maladies ?\nQuels aliments sont riches en flavonols ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Evidence-Based+Practice&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Flavonols", "description": "Les flavonols sont-ils utilisés en médecine ?\nComment les flavonols aident-ils dans le traitement du cancer ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Evidence-Based+Practice&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Flavonols", "description": "Y a-t-il des complications liées aux flavonols ?\nLes flavonols peuvent-ils causer des effets secondaires ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Evidence-Based+Practice&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Flavonols", "description": "Qui devrait éviter les flavonols ?\nLes flavonols sont-ils sûrs pour les femmes enceintes ?", "url": "https://questionsmedicales.fr/mesh/D044948?mesh_terms=Evidence-Based+Practice&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment détecte-t-on les flavonols dans les aliments ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent être détectés par chromatographie et spectrométrie de masse." } }, { "@type": "Question", "name": "Quels tests mesurent les niveaux de flavonols dans le sang ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins spécifiques peuvent quantifier les flavonols et leurs métabolites." } }, { "@type": "Question", "name": "Les flavonols provoquent-ils des symptômes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols ne provoquent pas de symptômes, mais des allergies peuvent survenir." } }, { "@type": "Question", "name": "Quels effets des flavonols sur la santé ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Les flavonols peuvent réduire l'inflammation et améliorer la santé cardiovasculaire." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils à prévenir les maladies ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils agissent comme antioxydants, réduisant le stress oxydatif et le risque de maladies." } }, { "@type": "Question", "name": "Quels aliments sont riches en flavonols ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les oignons, le thé, les baies et le chocolat noir sont de bonnes sources de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils utilisés en médecine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les flavonols sont étudiés pour leurs effets bénéfiques sur diverses maladies." } }, { "@type": "Question", "name": "Comment les flavonols aident-ils dans le traitement du cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent inhiber la croissance tumorale et améliorer l'efficacité des traitements." } }, { "@type": "Question", "name": "Y a-t-il des complications liées aux flavonols ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des interactions médicamenteuses peuvent survenir, mais elles sont rares." } }, { "@type": "Question", "name": "Les flavonols peuvent-ils causer des effets secondaires ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "En général, ils sont sûrs, mais des doses élevées peuvent entraîner des troubles digestifs." } }, { "@type": "Question", "name": "Qui devrait éviter les flavonols ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes allergiques aux flavonoïdes devraient limiter leur consommation de flavonols." } }, { "@type": "Question", "name": "Les flavonols sont-ils sûrs pour les femmes enceintes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "En général, les flavonols sont considérés comme sûrs, mais une consultation médicale est conseillée." } } ] } ] }

Sources (10000 au total)

Instruments for assessing healthcare professionals' knowledge and skills of evidence-based practice: A scoping review.

The aim of this scoping review was to describe the instruments used to assess the knowledge and skills of evidence-based practice (EBP) in healthcare settings.... A scoping review was undertaken. Three electronic databases (CINAHL, PubMed and Cochrane) were searched in January 2022. The search phrases consisted of the following terms: healthcare professionals, ... Ultimately, 39 studies were included; most of them (35) were cross-sectional studies. The studies were conducted in 17 countries. A total of 17 evidence-based knowledge and skills instruments were ide... Almost all instruments are self-assessment instruments. Validated knowledge tests should be further developed. The instruments emphasise the preparation for the implementation of EBP. Further research...

How nursing stakeholders in the Republic of Ireland define evidence-based practice and why it matters.

Evidence-based practice (EBP) has garnered increasing exposure in professional healthcare discourse over three decades. While the term is used frequently, its interpretation varies widely. An accurate... To establish nurses', midwives', educators', and students' knowledge and understanding of the concept of EBP in the Republic of Ireland.... In a national study exploring EBP beliefs, implementation, and organizational readiness for EBP among nurses, midwives, educators, and students, an open-ended question invited participants to explain ... Five themes emerged from the data from the single open-ended question: (1) varying definitions of EBP, (2) best practice, (3) nurses' and midwives' role in EBP, (4) knowledge, and (5) barriers and fac... Poor knowledge and understanding of EBP is a fundamental challenge to EBP implementation. Conflation of EBP with research utilization and other healthcare concepts is not uncommon among nurses and mid...

[Implementation of a checklist improves adherence to evidence-based practices in a pediatric intensive therapy unit].

Adherence to evidence-based practices (EBP) allows better management of the health-disease process in critical ill patients, with a close relationship between compliance and the quality achieved. We s... Controlled before-after study, developed at the PICU of the Pedro de Elizalde Children's General Hospital (PECGH), which involved all patients admitted in the period 12/01/2019 to 08/31/2020. The impl... During the study period, 153 patients were admitted to the PECGH PICU. The pre- and post-intervention groups were similar in mechanical ventilatory assistance (MVA) requirements and pre-established mo... The implementation of a CL allowed to increase compliance with the different EBP studied, a lower rate of MVA use, and a reduction in the rate of device-associated infections....

Chinese guidelines for the rehabilitation treatment of knee osteoarthritis: An CSPMR evidence-based practice guideline.

Knee osteoarthritis (KOA) is the most common degenerative joint disease in China, causing a huge economic burden on patients, families, and society. Standardized KOA rehabilitation treatment is an imp... Clinical questions regarding rehabilitation assessment and treatment were selected through clinical questions screening and deconstruction, and multiple rounds of Delphi questionnaire consultation. Th... The reporting of this guideline followed the standard of Reporting Items for Practice Guidelines in Healthcare (RIGHT). Taking into account patients' preferences and values and the needs of Chinese cl... This is the first evidence-based guideline for KOA rehabilitation in China utilizing the ICF framework. This guideline provides key guidance for developing systematic, standardized, and precise rehabi...

Nursing managers' perspectives on facilitators of and barriers to evidence-based practice: A cross-sectional study.

This study aimed to determine the facilitators and barriers to evidence-based practice (EBP) from the perspective of Iranian nursing managers.... Cross-sectional study.... Data were collected from 335 top nursing managers of Iran. The research instruments included three electronic questionnaires for demographics, facilitators and barriers of evidence-based practice. Des... A total of 277 nursing managers participated in the study (response rate of 82%). Iranian nursing managers believed that organizational factors were the most important domain for both facilitators (34...

Promoting Evidence-Based Practice: The Influence of Novel Structural Change to Accelerate Translational Rehabilitation.

To evaluate changes in clinicians' use of evidence-based practice (EBP), openness toward EBP, and their acceptance of organizational changes after a rehabilitation hospital transitioned to a new facil... Three repeated surveys of clinicians before, 7-9 months, and 2.5 years after transition to the new facility.... Inpatient rehabilitation hospital.... Physicians, nurses, therapists, and other health care professionals (n=410, 442, and 448 respondents at Times 1, 2, and 3, respectively).... Implementation of physical (architecture, design) and team-focused (champions, leaders, incentives) changes in a new model of care to promote clinician-researcher collaborations.... Adapted versions of the Evidence-Based Practice Questionnaire (EBPQ), the Evidence-Based Practice Attitudes Scale (EBPAS), and the Organizational Change Recipients' Beliefs Scale (OCRBS) were used. Op... Response rates at Times 1, 2, and 3 were 67% (n=410), 69% (n=422), and 71% (n=448), respectively. After accounting for familiarity with the model of care, there was greater reported use of EBP at Time... Accelerating clinician-researcher collaborations in a rehabilitation setting requires sustained effort for successful implementation beyond novel physical changes. Organizations must be responsive to ...

Evaluations of Probation Specialists on Evidence-Based Probation Practices: A Qualitative Study from Turkey.

This research explores the views of probation specialists working with young offenders about their professional process, professional problems, and the evidence-based practice approach.... The qualitative method was used in the research and the phenomenology pattern forms the basis of the research. The data deciphered and conceptualized with descriptive analysis by the organizing and se... According to data from in-depth interviews, due to the dual structure of the probation system, which includes both execution and rehabilitation, professional staff experience role conflict. Profession... There is a need for developing the effectiveness of intervention programs in the probation system and an evidence-based intervention system. At the end of the article, some suggestions on effective so...

Revisiting the policy ecology framework for implementation of evidence-based practices in mental health settings.

Over the past three decades, policy actors and actions have been highly influential in supporting the implementation of evidence-based practices (EBPs) in mental health settings. An early examination ... This paper builds upon the original PEF to address changes in the policy landscape for the implementation of mental health EBPs between 2009 and 2022. We review the current state of policy strategies ... We present an updated menu of policy strategies to support the implementation of EBPs in mental health settings. This updated menu of strategies considers the broad range of conceptual developments an...